NCT04060602 is a NA clinical trial of Personalized Feedback in Cannabis Use, sponsored by Centre for Addiction and Mental Health.

Who is sponsoring NCT04060602?

NCT04060602 is sponsored by Centre for Addiction and Mental Health.

What drugs are being tested in NCT04060602?

Interventions in NCT04060602: Personalized Feedback, Education.

What condition does NCT04060602 study?

NCT04060602 studies Cannabis Use.

Is NCT04060602 still recruiting?

NCT04060602 is currently completed. Last updated 27 October 2020.

Last reviewed 2020-10-27 · How we verify

NCT04060602

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Personalized Feedback Intervention to Reduce Risky Cannabis Use.

Completed NA Last updated 27 October 2020

What this trial tests

NA trial testing Personalized Feedback in Cannabis Use in 747 participants. Completed in 15 October 2020.

Timeline

3 September 2019

Primary endpoint
15 October 2020

15 October 2020

Quick facts

Lead sponsor	Centre for Addiction and Mental Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	747
Start date	3 September 2019
Primary completion	15 October 2020
Estimated completion	15 October 2020
Sites	1 location across Canada

Drugs / interventions tested

Personalized Feedback
Education

Conditions studied

Cannabis Use — all drugs for Cannabis Use →

Sponsor

Centre for Addiction and Mental Health — full company profile →

Who can join

Adults 18 to 99, any sex, with Cannabis Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this project is to determine whether participants who receive a personalized feedback report and educational materials about risky cannabis use will be less likely to report risky cannabis use at follow-up compared to participants who only received educational materials.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Online personalized feedback intervention to reduce risky cannabis use. Randomized controlled trial.
Cunningham JA, Schell C, Bertholet N, Wardell JD, et al · · 2021 · cited 7× · PMID 34824985 · DOI 10.1016/j.invent.2021.100484
Normative Misperceptions About Cannabis Use in a Sample of Risky Cannabis Users.
Cunningham JA, Schell C, Bertholet N, Wardell JD, et al · · 2023 · PMID 37051014 · DOI 10.1177/11782218231166809

Verify or expand the search:

Other trials of Personalized Feedback

Trials testing the same drug.

NCT04416711 — Alcohol And Sexual Risk Behavior · NA · completed
NCT04443153 — Adapting Diabetes Treatment Expert Systems to Patient in Type 1 Diabetes · NA · completed

Other recruiting trials for Cannabis Use

Currently open trials in the same condition.

NCT07196462 — Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia · NA · recruiting
NCT07168707 — Culturally Adapted EAET-H for Chronic Pain Patients Using Medical Cannabis in Israel - A Pilot Study · NA · recruiting
NCT05999383 — Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration · Phase 2 · recruiting
NCT06883162 — Cannabis-Tobacco Co-Use Treatment Study · Phase 3 · recruiting
NCT06699251 — Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat) · NA · recruiting

Other Centre for Addiction and Mental Health trials

Trials by the same sponsor.

NCT07211438 — Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression · Phase 2 · not yet recruiting
NCT07146633 — Efficacy of an EMDR App for PTSD and SUD · NA · recruiting
NCT07228923 — Development and Evaluation of a Theory and Evidence-based Intervention to Reduce Hazardous Alcohol Consumption Among Tre · NA · not yet recruiting
NCT07105449 — THC Titration of High-Potency Cannabis Concentrates · NA · not yet recruiting
NCT06928935 — Digital Dialectical Behavioural Therapy (d-DBT) for Youth at Clinical High Risk (CHR) for Psychosis · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04060602 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre for Addiction and Mental Health
Last refreshed: 27 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04060602.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing